Both in Pharmaceuticals
Palatin Technologies vs Cellectar Biosciences INC NEW
Over the past year PTN returned −53.7% and CLRB returned −65.1%; their daily moves had a correlation of 0.05.
PTN −53.7% CLRB −65.1%Growth of $1, one year, split-adjusted
| Metric | PTN | CLRB |
|---|---|---|
| Price | $5.11 | $1.22 |
| Market cap | $9.1M | $11.5M |
| Today | −7.26% | +4.27% |
| 1 month | −48.0% | −41.2% |
| 6 months | −77.0% | −55.8% |
| Year to date | −66.8% | −58.6% |
| 1 year | — | −68.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −1449.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.7× | — |
| Net cash | $7.5M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 108.1% | 67.0% |
| Short % of float | 22.3% | 1.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).